This study tackles significant industry issues with rigor and insight. It is a landmark study based on interviews with 362 patients, principal investigators and drug development professionals.
Respondents discuss in detail the drivers and barriers to successfully recruiting patients and investigators into clinical trials. The report contains 265 pages, including novel and insightful analysis and more than 250 charts and graphs.
This report contains the following four sections.
1. Trial Participant Analysis
- Attitudes and Information
- Create awareness, not interest
- Drivers of Clinical Trial Participation
- Recruitment channels
2. Principal Investigator Analysis
- Relationships – Sponsors or CROs?
- Site resources, Administration, and Productivity
3. Sponsor and Service Provider Analysis
- Lack of focus on Trial Participants
- CRO Responsibilities
- The Quality of Feasibility Studies
- Innovation in Recruiting Practices
4. Comparative Responses Analysis
As always, a full appendix of Charts and Graphs is included within this report with responses to all questions asked in this study.
What Readers Will Learn:
- What motivates patients to participate - or not participate - in clinical trials
- The bottlenecks in recruiting patients and investigators
- Investigators' preferences for working with sponsors or CROs
- Recruitment professionals' assessments of the most and least effective recruitment tools and channels
- Investigator, sponsor and CRO ideas for addressing the shortcomings in feasibility assessments
- The desirability of new engagement models for sponsors and CROs and much more
Other Measurements In This Report:
- Service Provider Performance and Selection
- Site Selection Control
- Investigator Incentive Program Success
- Magazine Advertising – Usage and Success
- Radio Advertising – Usage and Success
- Online Advertising – Usage and Success
- EDC Adoption and Effects on Trials
- Feasibility Perspectives
Purchasers of this report also purchased:
- The State of Biomarkers in Product Development
- The State of the Central Labs Market
- The Voice of the Site Coordinator
- The State of Adaptive Clinical Trials